Angiotensin receptor-neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure on replacement therapy

19 May 2025 (15:36 - 15:45)
Organised by: Logo
Congress Presentation Part of: Advancing heart failure diagnosis and management: insights from hemodynamics, inflammation, and emerging therapies Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)